Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
02 Aug 2021
Historique:
pubmed: 8 1 2021
medline: 16 12 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Intestinal ultrasound [IUS] is useful to assess inflammation in ulcerative colitis [UC] patients. We aimed to develop an ultrasonographic activity index using endoscopy as the reference standard. Patients were included consecutively. IUS was performed within 3 weeks from endoscopy. IUS parameters and endoscopy were compared for each colonic segment [except the rectum]. The best parameters were used to construct a UC-IUS index, which was correlated with endoscopic disease activity using the Spearman's rank test. In 60 patients, 207 colonic segments were evaluated endoscopically. Bowel wall thickness [BWT] > 2.1 mm was optimal to discriminate between Mayo 0 and Mayo 1-3 (sensitivity 82.6%; specificity 93.0%; area under the curve [AUC] 0.910), a cut-off of 3.2 mm was optimal to discriminate between Mayo 0-1 and Mayo 2-3 [sensitivity 89.1%; specificity 92.3%; AUC 0.946] and BWT > 3.9 mm was optimal for detection of Mayo 3 [sensitivity 80.6%; specificity 84.1%; AUC 0.909]. The presence of colour Doppler signal [CDS] predicted active disease, stretches of CDS were associated with Mayo 2-3, lack of haustrations predicted active disease and fat wrapping was associated with severe disease. Inter- and intra-rater intraclass correlation for BWT was substantial. Inter-rater agreement for CDS was substantial and ranged from slight to substantial for haustrations. Intra-rater agreement for CDS was substantial and ranged from moderate to almost perfect for haustrations. The index showed strong correlation with endoscopic disease activity [Mayo: ρ 0.830; p < 0.001, UCEIS: ρ 0.759; p < 0.001]. We developed an UC-IUS index which showed strong correlation with endoscopic disease activity using internal validation. It is currently being validated in prospective studies.

Identifiants

pubmed: 33411887
pii: 6067606
doi: 10.1093/ecco-jcc/jjab002
pmc: PMC8328285
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1264-1271

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

Références

J Crohns Colitis. 2018 Nov 28;12(12):1385-1391
pubmed: 30085066
Dig Liver Dis. 2011 Sep;43(9):703-6
pubmed: 21482208
Gut. 1998 Jul;43(1):29-32
pubmed: 9771402
J Crohns Colitis. 2012 Dec;6(10):965-90
pubmed: 23040452
Scand J Gastroenterol. 2014 Mar;49(3):295-301
pubmed: 24344807
J Crohns Colitis. 2017 Jun 1;11(6):649-670
pubmed: 28158501
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24
pubmed: 22344983
Ultraschall Med. 2012 Dec;33(7):E225-E232
pubmed: 22504939
Am J Gastroenterol. 2010 May;105(5):1150-7
pubmed: 19997096
J Crohns Colitis. 2018 Jul 30;12(8):920-929
pubmed: 29684200
Gut. 2012 Apr;61(4):535-42
pubmed: 21997563
BMC Gastroenterol. 2011 Mar 31;11:29
pubmed: 21453450
J Crohns Colitis. 2013 Mar;7(2):120-8
pubmed: 22483566
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436
N Engl J Med. 1987 Dec 24;317(26):1625-9
pubmed: 3317057
Inflamm Bowel Dis. 2004 Jul;10(4):373-82
pubmed: 15475745
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Scand J Gastroenterol. 1999 Nov;34(11):1103-7
pubmed: 10582761
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Inflamm Bowel Dis. 2013 Sep;19(10):2111-7
pubmed: 23883959
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
J Pediatr. 2014 Jul;165(1):78-84.e2
pubmed: 24725581
Inflamm Bowel Dis. 2009 Sep;15(9):1295-301
pubmed: 19340881
Gastroenterology. 2011 Oct;141(4):1194-201
pubmed: 21723220
Gut. 2011 Jan;60(1):3-9
pubmed: 21148578
Dig Dis. 2009;27(3):285-90
pubmed: 19786753
United European Gastroenterol J. 2016 Apr;4(2):314-8
pubmed: 27087962

Auteurs

Steven Bots (S)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, The Netherlands.

Kim Nylund (K)

National Centre for Ultrasound in Gastroenterology, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Mark Löwenberg (M)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, The Netherlands.

Krisztina Gecse (K)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, The Netherlands.

Geert D'Haens (G)

Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location AMC, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH